Breaking News Instant updates and real-time market news.

MRK

Merck

$62.51

0.85 (1.38%)

08:30
10/14/16
10/14
08:30
10/14/16
08:30

Merck announces launch of Biosimilars Clarified website

Merck announced the launch of Biosimilars Clarified, a new educational website for patients, caregivers and the healthcare community that is designed to provide clear, concise and straightforward information about biosimilar medicines.

  • 25

    Oct

  • 26

    Oct

  • 06

    Nov

MRK Merck
$62.51

0.85 (1.38%)

10/10/16
LEER
10/10/16
NO CHANGE
LEER
Market Perform
Merck 'steals the show' at ESMO with Keytruda data, says Leerink
Leerink analyst Seamus Fernandez said Merck (MRK) stole the show at ESMO with its Keytruda data and he continues to think the company will dominate first line lung cancer treatment for years to come in patients with 50%+ PDL1 expression. Additionally, he expects Merck to gain additional traction in the overall market, noting that confirmation that Keytruda is benefiting patients when combined with Alimta/carboplatin with Alimta maintenance raises the possibility Merck could compete broadly in the overall non-squamous patient population. However, Fernandez keeps a Market Perform rating on Merck, as he thinks its current valuation largely reflects improved growth prospects through 2020.
10/10/16
JMPS
10/10/16
NO CHANGE
JMPS
Incyte treatment looking 'promising,' says JMP Securities
After reviewing recent data, JMP Securities analyst Liisa Bayko says that the combination of Incyte's (INCY) Epacadostat plus Merck's (MRK) Keytruda is "emerging as a promising treatment, potentially even best in class." The analyst says that the progression free survival rate of the combination in melanoma patients "is emerging to be quite competitive," while the efficacy rate in other solid tumors "seemed encouraging." The analyst raised her price target on Incyte to $110 from $100 and keeps an Outperform rating on the stock.
10/13/16
BOFA
10/13/16
UPGRADE
Target $70
BOFA
Buy
Merck upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Colin Bristow upgraded Merck to Buy and raised its price target to $70 from $57 to reflect its opportunity in first line lung cancer. Bristow significantly raised his Keytruda sales estmate to 7.5B from $5.5B following Merck's first line lung cancer data presentations at ESMO over the weekend and feedback from experts. He expects Keytruda to receive early approval/launch in first line NSCLC from the December 24 PDUFA and to become the standard of care in the identified label and further upside from chemo combo.
10/13/16
10/13/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Merck (MRK) upgraded to Buy from Neutral at BofA/Merrill with analyst Colin Bristow citing its opportunity in first line lung cancer. 2. Viacom (VIA, VIAB) upgraded to Market Perform from Underperform at Wells Fargo and to Buy from Underperform at BofA/Merrill. 3. TD Ameritrade (AMTD) and Charles Schwab (SCHW) were upgraded to Buy from Neutral at BofA/Merrill. 4. Talend (TLND) upgraded to Buy from Neutral at Goldman with analyst Jesse Hulsing saying the company will benefit from analytic workloads moving to the cloud. 5. CSC (CSC) upgraded to Buy from Neutral at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

OKSB

Southwest Bancorp

$25.75

0.2 (0.78%)

16:33
04/25/17
04/25
16:33
04/25/17
16:33
Earnings
Breaking Earnings news story on Southwest Bancorp »

Southwest Bancorp reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

PEI

Pennsylvania REIT

$14.59

-0.01 (-0.07%)

16:33
04/25/17
04/25
16:33
04/25/17
16:33
Earnings
Pennsylvania REIT reports Q1 EPS (10c), consensus (8c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

CLGX

CoreLogic

$41.96

-0.14 (-0.33%)

16:32
04/25/17
04/25
16:32
04/25/17
16:32
Earnings
CoreLogic reports Q1 adjusted EPS 37c, consensus 39c »

Reports Q1 revenue $440M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

TXN

Texas Instruments

$82.37

1.29 (1.59%)

16:32
04/25/17
04/25
16:32
04/25/17
16:32
Hot Stocks
Breaking Hot Stocks news story on Texas Instruments »

Texas Instruments reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 31

    May

TXN

Texas Instruments

$82.37

1.29 (1.59%)

16:32
04/25/17
04/25
16:32
04/25/17
16:32
Earnings
Texas Instruments sees Q2 EPS 89c-$1.01, consensus 91c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 31

    May

JNS

Janus Capital

$13.45

0.02 (0.15%)

16:32
04/25/17
04/25
16:32
04/25/17
16:32
Hot Stocks
Janus Capital shareholders approve merger with Henderson Group »

Janus Capital Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

TRMK

Trustmark

$32.97

0.14 (0.43%)

16:31
04/25/17
04/25
16:31
04/25/17
16:31
Earnings
Trustmark reports Q1 EPS 46c, consensus 41c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

X

U.S. Steel

$31.11

-0.09 (-0.29%)

16:31
04/25/17
04/25
16:31
04/25/17
16:31
Hot Stocks
U.S. Steel drops over 15% in after-hours following earnings report »

U.S. Steel shares are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

16:31
04/25/17
04/25
16:31
04/25/17
16:31
Options
Preliminary option volume of 19.4M today »

Preliminary option volume…

TXN

Texas Instruments

$82.37

1.29 (1.59%)

16:30
04/25/17
04/25
16:30
04/25/17
16:30
Earnings
Texas Instruments reports Q1 EPS 97c, consensus 83c »

Reports Q1 revenue $3.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 31

    May

CHSP

Chesapeake Lodging

$24.70

0.29 (1.19%)

16:29
04/25/17
04/25
16:29
04/25/17
16:29
Earnings
Chesapeake Lodging sees Q2 AFFO 60c-64c »

Sees Q2 EPS 27c-30c,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 17

    May

TGI

Triumph Group

$26.20

-0.05 (-0.19%)

16:29
04/25/17
04/25
16:29
04/25/17
16:29
Hot Stocks
Triumph Group, VAS Aero collaborate on PW4168 Nacelles »

Triumph Group said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNPR

Juniper

$27.78

-0.49 (-1.73%)

16:28
04/25/17
04/25
16:28
04/25/17
16:28
Earnings
Juniper reports preliminary Q1 EPS 46c, consensus 42c »

Reports preliminary Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    May

  • 08

    Jun

CHSP

Chesapeake Lodging

$24.70

0.29 (1.19%)

16:28
04/25/17
04/25
16:28
04/25/17
16:28
Earnings
Chesapeake Lodging backs FY17 adjusted FFO $2.10-$2.20 »

Backs FY17 EPS 73c-83c,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 17

    May

ARCW

ARC Group

$3.85

0.05 (1.32%)

16:28
04/25/17
04/25
16:28
04/25/17
16:28
Hot Stocks
Breaking Hot Stocks news story on ARC Group »

Northern Right Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHSP

Chesapeake Lodging

$24.70

0.29 (1.19%)

16:27
04/25/17
04/25
16:27
04/25/17
16:27
Earnings
Chesapeake Lodging reports Q1 adjusted FFO 41c »

Reports Q1 EPS 9c,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 17

    May

BXMT

Blackstone Mortgage

$30.91

0.28 (0.91%)

16:26
04/25/17
04/25
16:26
04/25/17
16:26
Earnings
Blackstone Mortgage reports Q1 core EPS 61c, consensus 63c »

Reports book value of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCUR

Concurrent

$4.94

0.0626 (1.28%)

16:26
04/25/17
04/25
16:26
04/25/17
16:26
Hot Stocks
Concurrent announces availability of Origin Release 3 »

Concurrent announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHS

Universal Health

$121.42

0.52 (0.43%)

16:25
04/25/17
04/25
16:25
04/25/17
16:25
Earnings
Universal Health reports Q1 adjusted EPS $2.10, consensus $2.07 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

PCG

PG&E

$67.66

-0.13 (-0.19%)

, EIX

Edison International

$80.82

-0.12 (-0.15%)

16:25
04/25/17
04/25
16:25
04/25/17
16:25
Hot Stocks
PG&E, CA energy companies propose reforms to CPUC »

PG&E (PCG) joined…

PCG

PG&E

$67.66

-0.13 (-0.19%)

EIX

Edison International

$80.82

-0.12 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 01

    May

  • 02

    May

DECK

Deckers Brands

$58.74

0.4 (0.69%)

16:25
04/25/17
04/25
16:25
04/25/17
16:25
Technical Analysis
Deckers Brands spikes after saying it will review strategic alternatives »

The stock was last at $62…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVXS

AveXis

$78.74

-0.44 (-0.56%)

16:25
04/25/17
04/25
16:25
04/25/17
16:25
Conference/Events
AveXis to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 06

    Jun

TRN

Trinity Industries

16:24
04/25/17
04/25
16:24
04/25/17
16:24
Earnings
Trinity Industries sees 2017 EPS $1.00-$1.25 vs. prior outlook $1.00-$1.35 

Consensus $1.23.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 01

    May

  • 09

    May

CHFC

Chemical Financial

$50.36

-0.35 (-0.69%)

16:24
04/25/17
04/25
16:24
04/25/17
16:24
Earnings
Chemical Financial reports Q1 EPS 71c, consensus 70c »

Net interest income was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 03

    May

WK

Workiva

$16.80

-0.05 (-0.30%)

16:24
04/25/17
04/25
16:24
04/25/17
16:24
Hot Stocks
Workiva partners with Fastpath »

Workiva and Fastpath,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.